Page 148 - Read Online

Zhu et al. Function of Mcl-1 and its regulative relations with HCC

induced apoptosis in hepatocellular carcinoma cells by transcriptional S. Pyrogallol-based molecules as potent inhibitors of the antiapoptotic
repression of Mcl-1. Cell Signal 2012;24:1803-9. Bcl-2 proteins. J Med Chem 2007;50:1723-6.
104. Zhu H, Yang W, He LJ, Ding WJ, Zheng L, Liao SD, Huang P, Lu 109. Tang G, Ding K, Nikolovska-Coleska Z, Yang CY, Qiu S, Shangary
W, He QJ, Yang B. Upregulating Noxa by ER stress, celastrol exerts S, Wang R, Guo J, Gao W, Meagher J, Stuckey J, Krajewski K, Jiang
synergistic anti-cancer activity in combination with ABT-737 in S, Roller PP, Wang S. Structure-based design of flavonoid compounds
human hepatocellular carcinoma cells. PLoS One 2012;7:e52333. as a new class of small-molecule inhibitors of the anti-apoptotic Bcl-2
105. Wei J, Kitada S, Rega MF, Emdadi A, Yuan H, Cellitti J, Stebbins JL, proteins. J Med Chem 2007;50:3163-6.
Zhai D, Sun J, Yang L, Dahl R, Zhang Z, Wu B, Wang S, Reed TA, 110. Tang G, Nikolovska-Coleska Z, Qiu S, Yang CY, Guo J, Wang S.
Wang HG, Lawrence N, Sebti S, Reed JC, Pellecchia M. Apogossypol Acylpyrogallols as inhibitors of antiapoptotic Bcl-2 proteins. J Med
derivatives as antagonists of antiapoptotic Bcl-2 family proteins. Mol Chem 2008;51:717-20.
Cancer Ther 2009;8:904-13. 111. Chen KF, Su JC, Liu CY, Huang JW, Chen KC, Chen WL, Tai WT,
106. Stein RC, Joseph AE, Matlin SA, Cunningham DC, Ford HT, Shiau CW. A novel obatoclax derivative, SC-2001, induces apoptosis
Coombes RC. A preliminary clinical study of gossypol in advanced in hepatocellular carcinoma cells through SHP-1-dependent STAT3
human cancer. Cancer Chemother Pharmacol 1992;30:480-2. inactivation. Cancer Lett 2012;321:27-35.
107. Mi JX, Wang GF, Wang HB, Sun XQ, Ni XY, Zhang XW, Tang 112. Zhang Z, Song T, Zhang T, Gao J, Wu G, An L, Du G. A novel
JM, Yang DJ. Synergistic antitumoral activity and induction of BH3 mimetic S1 potently induces Bax/Bak-dependent apoptosis by
apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with targeting both Bcl-2 and Mcl-1. Int J Cancer 2011;128:1724-35.
adriamycin in human hepatocellular carcinoma. Acta Pharmacol Sin 113. Furuse J, Okusaka T, Kaneko S, Kudo M, Nakachi K, Ueno H,
2008;29:1467-77. Yamashita T, Ueshima K. Phase I/II study of the pharmacokinetics,
108. Tang G, Yang CY, Nikolovska-Coleska Z, Guo J, Qiu S, Wang R, safety and efficacy of S-1 in patients with advanced hepatocellular
Gao W, Wang G, Stuckey J, Krajewski K, Jiang S, Roller PP, Wang carcinoma. Cancer Sci 2010;101:2606-11.

140 Hepatoma Research ¦ Volume 3 ¦ July 06, 2017